Biocontrol activity of Bacillus subtilis EA-CB0015 cells and lipopeptides against postharvest fungal pathogens

dc.citation.journalTitleBIOLOGICAL CONTROLspa
dc.contributor.authorArroyave-Toro J.J.
dc.contributor.authorMosquera S.
dc.contributor.authorVillegas-Escobar V.
dc.contributor.departmentUniversidad EAFIT. Departamento de Cienciasspa
dc.contributor.researchgroupCiencias Biológicas y Bioprocesos (CIBIOP)spa
dc.date.accessioned2021-03-23T20:09:00Z
dc.date.available2021-03-23T20:09:00Z
dc.date.issued2017-11-01
dc.description.abstractPost-harvest diseases are responsible for significant losses worldwide, especially the plant pathogenic fungi Botrytis cinerea and Colletotrichum sp. are particularly severe and devastating. In this study, nine fungal pathogens were screened for growth inhibition by Bacillus subtilis EA-CB0015 strain and its metabolites. In vitro inhibitory assays showed that B. subtilis EA-CB0015 cells and the cell free supernatant (CFS) inhibited the growth of the tested fungal pathogens with different susceptibilities. Therefore, the antifungal activities of lipopeptides iturin A and fengycin C contained in the CFS, were tested against C. acutatum and B. cinerea. C. acutatum was more susceptible with minimal inhibitory concentrations (MIC) of 32 ppm (iturin A) and 128 ppm (fengycin C). Fruit and flower trials confirmed that B. subtilis EA-CB0015 cells and its lipopeptides reduced postharvest disease development but to differing degrees. Anthracnose symptoms caused by C. acutatum in tamarillo fruits were completely abolished by CFS, iturin A and fengycin C and reduced by 76% when treated with B. subtilis cells. In contrast, grey mold disease symptoms caused by B. cinerea in chrysanthemum flowers were inhibited by 72% when treated with lipopeptides and by 39% when applied with B. subtilis EA-CB0015 cells. Our results indicate that lipopeptides and cells of B. subtilis EA-CB0015 have a broad antifungal spectrum and control postharvest diseases caused by susceptible fungal pathogens. Our findings open the possibility of incorporating this biological control agent into different disease management programs.eng
dc.identifierhttps://eafit.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7518
dc.identifier.doi10.1016/j.biocontrol.2017.08.014spa
dc.identifier.issn10499644spa
dc.identifier.issn10902112spa
dc.identifier.otherPUBMED;30440633
dc.identifier.otherSCOPUS;2-s2.0-85056638520
dc.identifier.urihttp://hdl.handle.net/10784/26828
dc.language.isoengeng
dc.publisherAcademic Press Inc.
dc.relation.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85028744140&doi=10.1016%2fj.biocontrol.2017.08.014&partnerID=40&md5=fec0a768ce1baedca984f95a9730f6a6
dc.rightshttps://v2.sherpa.ac.uk/id/publication/issn/1049-9644
dc.sourceBIOLOGICAL CONTROL
dc.subject.keywordBiological controleng
dc.subject.keywordLipopeptideseng
dc.subject.keywordFengycin Ceng
dc.subject.keywordIturineng
dc.subject.keywordColletotrichum acutatumeng
dc.subject.keywordBotrytis cinereaeng
dc.titleBiocontrol activity of Bacillus subtilis EA-CB0015 cells and lipopeptides against postharvest fungal pathogenseng
dc.typearticleeng
dc.typeinfo:eu-repo/semantics/articleeng
dc.typeinfo:eu-repo/semantics/publishedVersioneng
dc.typepublishedVersioneng
dc.type.localArtículo

Archivos

Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
1-s2.0-S1049964417301779-main.pdf
Tamaño:
258.67 KB
Formato:
Adobe Portable Document Format
Descripción: